Literature DB >> 15205221

Refraction and keratometry in premature infants.

M X Repka.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15205221      PMCID： PMC1772239          DOI： 10.1136/bjo.2003.041186

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Ocular growth and refractive error development in premature infants without retinopathy of prematurity.

Authors:  Anne Cook; Sarah White; Mark Batterbury; David Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

2.  A population-based study of the refractive outcome in 10-year-old preterm and full-term children.

Authors:  Eva K Larsson; Agneta C Rydberg; Gerd E Holmström
Journal:  Arch Ophthalmol       Date:  2003-10

3.  Myopia of prematurity: nature, nurture, or disease?

Authors:  A R Fielder; G E Quinn
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.

Authors:  G E Quinn; V Dobson; R Siatkowski; R J Hardy; J Kivlin; E A Palmer; D L Phelps; M X Repka; C G Summers; B Tung; W Chan
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

5.  Anterior segment abnormalities in cicatricial retinopathy of prematurity.

Authors:  H M Hittner; L M Rhodes; A R McPherson
Journal:  Ophthalmology       Date:  1979-05       Impact factor: 12.079

6.  Corneal curvatures in premature infants.

Authors:  P B Donzis; M S Insler; R A Gordon
Journal:  Am J Ophthalmol       Date:  1985-02-15       Impact factor: 5.258

7.  Temperature--a factor in ocular development?

Authors:  A R Fielder; M I Levene; I M Russell-Eggitt; R A Weale
Journal:  Dev Med Child Neurol       Date:  1986-06       Impact factor: 5.449
  7 in total
  1 in total

1.  Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes.

Authors:  Y-H Chen; S-N Chen; R-I Lien; C-P Shih; A-N Chao; K-J Chen; Y-S Hwang; N-K Wang; Y-P Chen; K-H Lee; C-C Chuang; T-L Chen; C-C Lai; W-C Wu
Journal:  Eye (Lond)       Date:  2014-08-08       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.